scholarly article | Q13442814 |
P50 | author | Adrian Boey | Q60732359 |
Tom J Carney | Q63488495 | ||
Xiaomeng Wang | Q86628171 | ||
P2093 | author name string | Wanjin Hong | |
Veluchamy A Barathi | |||
Madhura Kulkarni | |||
Gandhi T K Boopathy | |||
Sze Yuan Ho | |||
Edmond Wei Min Chua | |||
P2860 | cites work | BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources | Q21183895 |
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt | Q22010149 | ||
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation | Q22010150 | ||
Purification and characterization of a major phosphatidylserine-binding phosphoprotein from human platelets | Q24313089 | ||
Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures | Q24679747 | ||
Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor | Q28139202 | ||
Retinopathy in diabetes | Q28166601 | ||
Regulation of endothelial nitric oxide synthase: location, location, location | Q28217344 | ||
Morpholino antisense oligomers: design, preparation, and properties | Q28243074 | ||
Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression | Q28243109 | ||
Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity | Q28244026 | ||
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia | Q28508302 | ||
PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function | Q28511660 | ||
Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling | Q28592810 | ||
Cellular regulation of endothelial nitric oxide synthase | Q28609853 | ||
Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling | Q28609890 | ||
Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo | Q28609900 | ||
Molecular mechanisms and clinical applications of angiogenesis | Q29547314 | ||
Angiogenesis in health and disease | Q29614541 | ||
Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice | Q29615180 | ||
Molecular regulation of angiogenesis and lymphangiogenesis | Q29616150 | ||
Proteomics. Tissue-based map of the human proteome | Q29617248 | ||
The multiple faces of caveolae | Q29618099 | ||
In vivo imaging of embryonic vascular development using transgenic zebrafish | Q29619921 | ||
SDPR induces membrane curvature and functions in the formation of caveolae | Q30090231 | ||
Cell surface orifices of caveolae and localization of caveolin to the necks of caveolae in adipocytes. | Q30480602 | ||
Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis | Q30542079 | ||
Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subcellular targeting | Q33722544 | ||
Lipocalin-7 Is a Matricellular Regulator of Angiogenesis | Q33749832 | ||
CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation | Q33917557 | ||
Microparticles in cardiovascular diseases. | Q34221054 | ||
Membrane microparticles: two sides of the coin | Q34384910 | ||
Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? | Q34443514 | ||
Endothelial cell migration during angiogenesis | Q34613912 | ||
VEGF-A and the induction of pathological angiogenesis | Q34718259 | ||
Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance | Q34847724 | ||
PKCzeta decreases eNOS protein stability via inhibitory phosphorylation of ERK5. | Q35215421 | ||
Endothelial microparticles: sophisticated vesicles modulating vascular function | Q35624092 | ||
Caveolae, caveolins, cavins, and endothelial cell function: new insights. | Q35656478 | ||
Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity | Q36048670 | ||
Development of the retinal vasculature | Q36745434 | ||
Deletion of cavin genes reveals tissue-specific mechanisms for morphogenesis of endothelial caveolae. | Q36906745 | ||
Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration | Q37241319 | ||
Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells | Q37376612 | ||
Caveolae at a glance | Q37806884 | ||
The many faces of endothelial microparticles. | Q37821169 | ||
Regulation of eNOS in caveolae | Q37992928 | ||
Building blood vessels in development and disease | Q38097264 | ||
Identification and angiogenic role of the novel tumor endothelial marker CLEC14A. | Q39517637 | ||
Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. | Q40020452 | ||
The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease | Q40418229 | ||
Generation of human pulmonary microvascular endothelial cell lines | Q40763667 | ||
In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. | Q40851071 | ||
Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase | Q42061558 | ||
Biogenesis of caveolae: stepwise assembly of large caveolin and cavin complexes | Q43195594 | ||
Oxygen-induced retinopathy: a model for vascular pathology in the retina. | Q43221726 | ||
Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities | Q43678714 | ||
Expression of genes involved in vascular development and angiogenesis in endothelial cells of adult lung. | Q45934495 | ||
The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractions | Q46855022 | ||
Calpain activation in plasma membrane bleb formation during tert-butyl hydroperoxide-induced rat hepatocyte injury. | Q54021698 | ||
Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. | Q55067651 | ||
Endothelial Microparticle Formation by Angiotensin II Is Mediated via Ang II Receptor Type I/NADPH Oxidase/ Rho Kinase Pathways Targeted to Lipid Rafts | Q56991404 | ||
Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes | Q71585776 | ||
The role of nitric oxide on endothelial function | Q82656325 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 43 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 17760-17776 | |
P577 | publication date | 2017-09-14 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Cavin-2 regulates the activity and stability of endothelial nitric-oxide synthase (eNOS) in angiogenesis | |
P478 | volume | 292 |
Q57115924 | An Update on Hydrogen Sulfide and Nitric Oxide Interactions in the Cardiovascular System |
Q52576145 | Bioinformatic Integration of Molecular Networks and Major Pathways Involved in Mice Cochlear and Vestibular Supporting Cells. |
Q92906598 | Insights into Early Recovery from Influenza Pneumonia by Spatial and Temporal Quantification of Putative Lung Regenerating Cells and by Lung Proteomics |
Q90260616 | Lung Endothelial Transcytosis |
Q49741768 | Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse |
Q99630348 | Prognostic and diagnostic significance of Cavin 2 in lung adenocarcinoma |
Search more.